Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates.

Abstract

This paper reviews an early clinical experience with anthracycline (epirubicin; Epi or doxorubicin; Dox) containing an N-(2-hydroyxypropyl)methacrylamide copolymer carrier targeted with autologous or commercial human immunoglobulin in six patients aged 28-55 suffering from therapy-resistant metastatic cancer. More than 100 biochemical, hematological and… (More)
DOI: 10.1016/j.addr.2008.12.017

Cite this paper

@article{hov2009ClinicalEW, title={Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates.}, author={Blanka Ř{\'i}hov{\'a}}, journal={Advanced drug delivery reviews}, year={2009}, volume={61 13}, pages={1149-58} }